Evidence map›Paper›PMID 19755676›Full record

ArticleBlood2009

TC-PTP is required for the maintenance of MYC-driven B-cell lymphomas.

Ryan M Young, Avital Polsky, Yosef Refaeli

Abstract read
In one paragraph

Article in Blood, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review.International journal of molecular sciences · 2022
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ryan M YoungDepartment of Dermatology, Charles C. Gates Regenerative Medicine and Stem Cell Program, University of Colorado Denver Health Sciences Center, Aurora, CO 80045, USA.
Avital Polsky
Yosef Refaeli

Funding

MYC-induced breach of B-cell anergy in AIDS-related NHLsR01CA117802 · NCI · UNIVERSITY OF COLORADO DENVER · PI REFAELI, YOSEF · 2006 to 2010
$1.5M
NCI NIH HHS CA-117802NCI NIH HHS R01 CA117802
6 · The paper itself

Abstract

We sought to determine the contributions of protein tyrosine phosphatases (PTPs) to the pathogenesis of B-cell lymphomas. We found that T-cell PTP (TC-PTP) was overexpressed in transformed B cells. We hypothesized that TC-PTP may be a tumor-promoting gene that is regulated by MYC overexpression in B cells. Knockdown of TC-PTP in murine tumors resulted in decreased cell viability in vitro because of an arrest in the G(1) phase of the cell cycle. Furthermore, cells with reduced TC-PTP expression were unable to either engraft or expand in vivo. Taken together, these data indicate that TC-PTP is required for B-cell tumor maintenance. Our data also suggested a correlation between TC-PTP expression and MYC overexpression. To investigate this further, we used malignant murine B cells that contain a doxycycline-repressible MYC transgene. We found that repression of MYC overexpression with doxycycline reduced TC-PTP expression. Moreover, enforced expression of TC-PTP showed partial rescue of the expansion of tumor cells after suppression of MYC overexpression. These results suggest that MYC overexpression induces TC-PTP overexpression, which in turn promotes tumor proliferation, implicating TC-PTP as an important effector of the MYC-driven proliferation program in B-cell lymphomas. Thus, TC-PTP may be a suitable molecular target for the treatment of B-cell lymphomas.

Indexed as

AnimalsBlotting, WesternCell Line, TumorGene ExpressionGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansLymphoma, B-CellMiceMice, TransgenicProtein Tyrosine Phosphatase, Non-Receptor Type 2Proto-Oncogene Proteins c-mycReverse Transcriptase Polymerase Chain ReactionProtein Tyrosine Phosphatase, Non-Receptor Type 2Proto-Oncogene Proteins c-mycPtpn2 protein, mouse

Identifiers

PMID19755676
PMCPMC2788975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.